{"chebi_id":"52289","chebi_name":"wortmannin","chebi_synonyms":["(1S,6bR,9aS,11R,11bR)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate","Wartmannin"],"diffprof_id_observed":["MTBLS7584_0003_00000003"],"diffprof_id_var_observed":[],"inchikey":"QDLHCMPXEPAAMD-QAIWCSMKSA-N","inn_name":"","iupac_name":"(1<i>S</i>,6b<i>R</i>,9a<i>S</i>,11<i>R</i>,11b<i>R</i>)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3<em>H</em>-furo[4,3,2-<em>de</em>]indeno[4,5-<em>h</em>]isochromen-11-yl acetate","num_study_observed":1,"reactome_ids":["R-HSA-1643685","R-HSA-2219528","R-HSA-2219530","R-HSA-5663202"],"reactome_names":["Disease","PI3K/AKT Signaling in Cancer","Constitutive Signaling by Aberrant PI3K in Cancer","Diseases of signal transduction by growth factor receptors and second messengers"],"study_id_observed":["MTBLS7584"],"study_id_var_observed":[],"synonym_name":"Wartmannin"}